ArticleCancer discovery2012

PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition.

Yasir H Ibrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.